Clinical Trial Update: Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction [Phase 4]

View source ↗

Summary

Clinical trial update for early intracoronary administration of fasudil in primary PCI for ST-segment elevation myocardial infarction (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• fasudil (fasudil)

Snippet

Sponsor: RenJi Hospital | Conditions: ST Segment Elevation Myocardial Infarction | Phase 4 | Status: UNKNOWN